Peripheral effects of the κ-opioid agonist EMD 61753 on pain and inflammation in rats and humans

Journal of Pharmacology and Experimental Therapeutics

Volumn 290, Issue 1, 1999, Pages 354-361

  Machelska, Halina ^a,b,c,d   Pflüger, Martina ^b,e   Weber, Werner ^b,e   Piranvisseh Völk, Mojgan ^b,e   Daubert, Jeffrey D ^b,f   Dehaven, Robert ^b,f   Stein, Christoph ^b,c,d  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d FREIE UNIVERSITÄT BERLIN   (Germany)

^e UNIVERSITY OF MUNICH   (Germany)

^f ADOLOR CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

17 METHYLNALOXONE; ASIMADOLINE; BINALTORPHIMINE; DIZOCILPINE; FREUND ADJUVANT; KAPPA OPIATE RECEPTOR AGONIST;

ADULT; ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CENTRAL NERVOUS SYSTEM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG TOLERABILITY; FEMALE; HUMAN; INFLAMMATION; INTRAPERITONEAL DRUG ADMINISTRATION; KNEE ARTHROSCOPY; KNEE SURGERY; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PAIN ASSESSMENT; PAIN THRESHOLD; POSTOPERATIVE PAIN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

ACETAMIDES; ADULT; ANALGESICS, OPIOID; ANIMALS; ARTHRITIS, EXPERIMENTAL; ARTHROSCOPY; BEHAVIOR, ANIMAL; CHO CELLS; CRICETINAE; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INFLAMMATION; KNEE JOINT; MALE; PAIN; PAIN MEASUREMENT; PAIN THRESHOLD; PAIN, POSTOPERATIVE; PYRROLIDINES; RATS; RATS, WISTAR; RECEPTORS, OPIOID, KAPPA;

EID: 0344731442     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Barber A, Bartoszyk GD, Bender HM, Gottschlich R, Greiner HE, Harting J, Mauler F, Minck KO, Murray RD, Simon M and Seyfried CA (1994) A pharmacological profile of the novel, peripherally-selective kappa-opioid receptor agonist, EMD 61753. Br J Pharmacol 113:1317-1327.
2. Barber A and Gottschlich R (1992) Opioid agonists and antagonists: An evaluation of their peripheral actions in inflammation. Med Res Rev 12:525-562.
3. Barber A and Gottschlich R (1997) Central and peripheral nervous system. Novel developments with selective, non-peptidic kappa-opioid receptor agonists. Exp Opin Invest Drugs 6:1351-1368.
4. Beyer A, Schäfer M and Stein C (1997) Antinociceptive effects of dynorphin peptides in a model of inflammatory pain. Pain 70:141-147.
5. Binder W and Walker JS (1998) Effect of the peripherally selective κ-opioid agonist, asimadoline, on adjuvant arthritis. Br J Pharmacol 124:647-654.
6. Bong GW, Rosengren S and Firestein GS (1996) Spinal cord adenosine receptor stimulation in rats inhibits peripheral neutrophil accumulation. The role of N-methyl-D-aspartate receptors. J Clin Invest 12:2779-2785.
7. Bryant HU and Holaday JW (1993) Opioids in immunologic processes, in Handbook of Experimental Pharmacology: Opioids II (Herz A ed) pp 551-570, Springer-Verlag, New York.
8. Casale T, Nowman S and Kaliner M (1984) Induction of human cutaneous mast cell degranulation by opiates and endogenous opioid peptides: Evidence for opiate and non-opiate receptor participation. J Allergy Clin Immunol 73:775-781.
9. Chahl LA and Chahl JS (1986) Plasma extravasation induced by dynorphin-(1-13) in rat skin. Eur J Pharamcol 124:343-347.
10. Charlton E (1995) Ethical guidelines for pain research in humans. Pain 63:277-278.
11. Chen L, Gu Y and Huang LY (1995) The opioid peptide dynorphin directly blocks NMDA receptor channels in the rat. J Physiol 482:575-581.
12. Coderre TJ, Basbaum AI, Dallman MF, Helms C and Levine JD (1990) Epinephrine exacerbates arthritis by an action at presynaptic B2-adrenoceptors. Neuroscience 34:521-523.
13. Crain SM and Shen K-F (1990) Opioids can evoke direct receptor-mediated excitatory effects on sensory neurons. Trends Pharmacol Sci 11:77-81.
14. Earl JR, Claxson AW, Blake DR and Morris CJ (1994) Proinflammatory effects of morphine in the rat adjuvant arthritis model. Int J Tiss React XVI:163-170.
15. Faden AI (1992) Dynorphin increases extracellular levels of excitatory amino acids in the brain through a non-opioid mechanism. J Neurosci 12:425-429.
16. Giardina G, Clarke GD, Grugni M, Sbacchi M and Vecchietti V (1995) Central and peripheral analgesic agents: Chemical strategies for limiting brain penetration in kappa-opioid agonists belonging to different chemical classes. Farmaco 50:405-418.
17. Haley J, Ketchum S and Dickenson A (1990) Peripheral κ-opioid modulation of the formalin response: An electrophysiological study in the rat. Eur J Pharmacol 191:437-446.
18. Hall TJ, Jagher B, Schaeublin M and Wiesenberg I (1996) The analgesic drug buprenorphine inhibits osteoclastic bone resorption in vitro, but is proinflammatory in rat adjuvant arthritis. Inflamm Res 45:299-302.
19. Hong Y and Abbott FV (1995) Peripheral opioid modulation of pain and inflammation in the formalin test. Eur J Pharamcol 277:21-28.
20. Horwell DC (1988) Kappa opioid analgesics. Drugs Future 13:1061-1070.
21. Kest B, Marek P and Liebeskind JC (1992) The specific N-methyl-D-aspartate (NMDA) receptor antagonist MK-801 blocks U-50,488, but not morphine antinociception. Brain Res 589:139-142.
22. Laughlin TM, Vanderah TW, Lashbrook J, Nichols ML, Ossipow M, Porreca F and Wilcox GL (1997) Spinally administered dynorphin A produces long-lasting allodynia: Involvement of NMDA but not opioid receptors. Pain 72:253-260.
23. Pfeiffer A, Brantl V, Herz A and Emrich HM (1986) Psychomimesis mediated by κ-opioid receptors. Science (Wash DC) 233:774-776.
24. Raynor K, Kong H, Chen Y, Yasuda K, Yu L, Bell GI and Reisine T (1994) Pharmacological characterization of the cloned κ-, δ-, and μ-opioid receptors. Mol Pharmacol 45:330-334.
25. Saucier DM and Kavaliers M (1994) Antagonistic effects of the selective, competitive N-methyl-D-aspartate (NMDA) receptor antagonist, NPC 12626, on kappa opiate-induced analgesia in male deer mice. Brain Res 637:292-296.
26. Shukla VK and Lemaire S (1994) Non-opioid effects of dynorphins: Possible role of the NMDA receptor. Trends Pharmacol Sci 15:420-424.
27. Stein C (1993) Peripheral mechanisms of opioid analgesia. Anesth Analg 76:182-191.
28. Stein C (1995) The control of pain in peripheral tissue by opioids. N Engl J Med 332:1685-1690.
29. Stein C, Pflüger M, Yaasouridis A, Lehrberger K, Welte C and Hassan AHS (1996) No tolerance to peripheral morphine analgesia in presence of opioid expression in inflamed synovia. J Clin Ivest 98:793-799.
30. Suarez-Roca H and Maixner WJ (1993) Activation of κ opioid receptors by U50488H and morphine enhances the release of substance P from rat trigeminal nucleus slices. J Pharmacol Exp Ther 264:648-653
31. Yu XM, Sessle BJ, Haas DA, Izzo A, Vernon H and Hu JW (1996) Involvement of NMDA receptor mechanisms in jaw electromyographic activity and plasma extravasation induced by inflammatory irritant application to temporomandibular joint region of rats. Pain 68:169-178.